Expression of RANKL/OPG during bone remodeling in vivo

Biochemical and Biophysical Research Communications

Volumn 411, Issue 4, 2011, Pages 690-694

  Tanaka, H ^a,b   Mine, T ^c   Ogasa, H ^b,c   Taguchi, T ^c   Liang, C T ^b,d  

^a Yamaguchi Grand Medical Center   (Japan)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bone remodeling; Osteoprotegerin (OPG); Receptor activator of nuclear factor B ligand (RANKL)

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OSTEOPROTEGERIN; PROCOLLAGEN; PROCOLLAGEN ALPHA 1; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMUR; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE STUDY; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BONE REMODELING; FEMUR; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC MARKERS; MALE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; RANK LIGAND; RATS; RATS, WISTAR;

RATTUS;

EID: 80051572677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.001     Document Type: Article

References (22)

1. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:9-319.
2. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:65-176.
3. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., Sato Y., Goto M., Yamaguchi K., Kuriyama M., Kanno T., Murakami A., Tsuda E., Morinaga T., Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998, 139:329-1337.
4. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 1998, 95:597-3602.
5. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., Timms E., Tan H.L., Elliott G., Kelley M.J., Sarosi I., Wang L., Xia X.Z., Elliott R., Chiu L., Black T., Scully S., Capparelli C., Morony S., Shimamoto G., Bass M.B., Boyle W.J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl Acad. Sci. USA 1999, 96:540-3545.
6. Kartsogiannis V., Zhou H., Horwood N.J., Thomas R.J., Hards D.K., Quinn J.M., Niforas P., Ng K.W., Martin T.J., Gillespie M.T. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 1999, 25:25-534.
7. Silvestrini G., Ballanti P., Patacchioli F., Leopizzi M., Gualtieri N., Monnazzi P., Tremante E., Sardella D., Bonucci E. Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat. J. Mol. Histol. 2005, 36:9-67.
8. Liang C.T., Barnes J., Seedor J.G., Quartuccio H.A., Bolander M., Jeffrey J.J., Rodan G.A. Impaired bone activity in aged rats: alterations at the cellular and molecular levels. Bone 1992, 13:35-441.
9. Tanaka H., Quarto R., Williams S., Barnes J., Liang C.T. In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. Bone 1994, 15:47-653.
10. Tanaka H., Wakisaka A., Ogasa H., Kawai S., Liang C.T. Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J. Endocrinol. 2002, 174:3-70.
11. Gori F., Hofbauer L.C., Dunstan C.R., Spelsberg T.C., Khosla S., Riggs B.L. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 2000, 141:768-4776.
12. Thomas G.P., Baker S.U., Eisman J.A., Gardiner E.M. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 2001, 170:51-460.
13. Atkins G.J., Kostakis P., Pan B., Farrugia A., Gronthos S., Evdokiou A., Harrison K., Findlay D.M., Zannettino A.C. RANKL expression is related to the differentiation state of human osteoblast. J. Bone Miner. Res. 2003, 18:88-1098.
14. Nemeth G.G., Heydemann A., Bolander M.E. Isolation and analysis of ribonucleic acids from skeletal tissues. Anal. Biochem. 1989, 183:1-304.
15. Noda M., Yoon K., Thiede M., Buenaga R., Weiss M., Henthorn P., Harris H., Rodan G.A. cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells. J. Bone Miner. Res. 1987, 2:61-164.
16. Genovese C., Rowe D., Kream B. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 1984, 23:210-6216.
17. Weinreb M., Shinar D., Rodan G.A. Different pattern of alkaline phosphatase osteopontin and osteocalcin expression in developing rat bone visualized by in situ hybridization. J. Bone Miner. Res. 1990, 5:31-842.
18. Yoon K., Buenaga R., Rodan G.A. Tissue specificity and developmental expression of rat osteopontin. Biochem. Biophys. Res. Commun. 1987, 148:129-1136.
19. Patt H.M., Maloney M.A. Bone marrow regeneration after local injury: a review. Exp. Hematol. 1975, 3:35-148.
20. Kon T., Cho T.J., Aizawa T., Yamazaki M., Nooh N., Graves D., Gerstenfeld L.C., Einhorn T.A. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J. Bone Miner. Res. 2001, 16:4-1014.
21. Zhu W.Q., Wang X., Wang X.X., Wang Z.Y. Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand during mandibular distraction in rats. J. Craniomaxillofac. Surg. 2007, 35:3-111.
22. de Amorim F.P., Ornelas S.S., Diniz S.F., Batista A.C., da Silva T.A. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. J. Mol. Histol. 2008, 39:1-408.